| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
84,906 |
33,794 |
$2.57M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
58,452 |
23,921 |
$649K |
| 99199 |
Unlisted special service, procedure or report |
78,588 |
46,185 |
$464K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
21,541 |
13,293 |
$365K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,266 |
3,762 |
$220K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
22,602 |
14,656 |
$189K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,804 |
9,743 |
$150K |
| 0001A |
|
5,483 |
2,577 |
$104K |
| 0002A |
|
4,789 |
2,193 |
$84K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,283 |
1,488 |
$66K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,638 |
1,857 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,351 |
784 |
$53K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
199 |
131 |
$40K |
| 0072A |
|
1,165 |
808 |
$39K |
| 0071A |
|
1,129 |
784 |
$38K |
| 0003A |
|
675 |
486 |
$21K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
85 |
55 |
$20K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
332 |
143 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,000 |
1,265 |
$15K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
214 |
116 |
$14K |
| 0012A |
|
662 |
248 |
$10K |
| 0011A |
|
725 |
262 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
433 |
129 |
$8K |
| 0073A |
|
121 |
88 |
$6K |
| 99401 |
|
1,107 |
778 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
384 |
130 |
$5K |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
21 |
14 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
598 |
433 |
$4K |
| 0031A |
|
241 |
91 |
$4K |
| 0004A |
|
79 |
62 |
$3K |
| 0013A |
|
134 |
95 |
$2K |
| 81025 |
|
556 |
380 |
$2K |
| 81002 |
|
1,698 |
1,097 |
$2K |
| 99051 |
|
74 |
60 |
$1K |
| 0111A |
|
37 |
18 |
$1K |
| 0112A |
|
38 |
23 |
$1K |
| 90834 |
Psychotherapy, 45 minutes with patient |
66 |
28 |
$1K |
| 86328 |
|
23 |
15 |
$723.68 |
| 90791 |
Psychiatric diagnostic evaluation |
23 |
14 |
$482.67 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
53 |
17 |
$474.82 |
| 86308 |
|
127 |
82 |
$282.32 |
| 36415 |
Collection of venous blood by venipuncture |
415 |
215 |
$279.90 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
202 |
85 |
$253.37 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
22 |
12 |
$172.90 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28 |
24 |
$165.30 |
| 83986 |
|
33 |
25 |
$13.89 |
| 94760 |
|
61 |
53 |
$4.14 |
| 3008F |
|
590 |
316 |
$0.02 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
391 |
299 |
$0.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
60 |
25 |
$0.00 |
| 99000 |
|
18 |
15 |
$0.00 |
| 99072 |
|
14 |
12 |
$0.00 |